Individual Variation in Lipidomic Profiles of Healthy Subjects in Response to Omega-3 Fatty Acids
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Conflicting findings in both interventional and observational studies have resulted in a lack of consensus on the benefits of ω3 fatty acids in reducing disease risk. This may be due to individual variability in response. We used a multi-platform lipidomic approach to investigate both the consistent and inconsistent responses of individuals comprehensively to a defined ω3 intervention. METHODS: The lipidomic profile including fatty acids, lipid classes, lipoprotein distribution, and oxylipins was examined multi- and uni-variately in 12 healthy subjects pre vs. post six weeks of ω3 fatty acids (1.9 g/d eicosapentaenoic acid [EPA] and 1.5 g/d docosahexaenoic acid [DHA]). RESULTS: Total lipidomic and oxylipin profiles were significantly different pre vs. post treatment across all subjects (p=0.00007 and p=0.00002 respectively). There was a strong correlation between oxylipin profiles and EPA and DHA incorporated into different lipid classes (r(2)=0.93). However, strikingly divergent responses among individuals were also observed. Both ω3 and ω6 fatty acid metabolites displayed a large degree of variation among the subjects. For example, in half of the subjects, two arachidonic acid cyclooxygenase products, prostaglandin E2 (PGE2) and thromboxane B2 (TXB2), and a lipoxygenase product, 12-hydroxyeicosatetraenoic acid (12-HETE) significantly decreased post intervention, whereas in the other half they either did not change or increased. The EPA lipoxygenase metabolite 12-hydroxyeicosapentaenoic acid (12-HEPE) varied among subjects from an 82% decrease to a 5,000% increase. CONCLUSIONS: Our results show that certain defined responses to ω3 fatty acid intervention were consistent across all subjects. However, there was also a high degree of inter-individual variability in certain aspects of lipid metabolism. This lipidomic based phenotyping approach demonstrated that individual responsiveness to ω3 fatty acids is highly variable and measurable, and could be used as a means to assess the effectiveness of ω3 interventions in modifying disease risk and determining metabolic phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have observed individual rate uptakes of omega-3 PUFAs into tissues [35], so the same supplementation period and dose may lead to different tissue levels of omega-3 PUFAs between subjects, potentially masking any effect of elevating omega-3 PUFA tissue levels.”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is now understood that different people respond differently to foods and nutrients, warranting personalized approaches to nutrition interventions and services [3,17-21].”
From Wearable Technology to Quantify the Nutritional Intake of Adults: Validation Study (2020) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There is also a degree of individual variation in the lipidome following omega-3 supplementation in humans which may be a factor in the equivocal metabolic changes measured in many human supplementation trials [35].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [35]
In the citing paper
“Subsequent studies observed that a period of omega-3 supplementation reduced risk factors associated with CVD, such as the lowering of plasma triacylglycerides (TAGs) and an increase in high density lipoproteins at the expense of low density lipoproteins, as well as decreasing in platelet aggregation [35,38,39].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · cited 1×
“modified Folch extraction in chloroform:methanol (2:1 v/v) [29].”
MethodWold, S., Esbensen, K., & Geladi, P. (1987) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/0169-7439(87)80084-9 · Cited by 11,606
Simopoulos, A. P. (2008) · Experimental Biology and Medicine · doi:10.3181/0711-mr-311 · Cited by 2,915 · cited 1×
“This represents a ratio of ω6:ω3 of 10:1, whereas estimates of historic intakes are closer to 1:1 [56].”
BackgroundPsychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., Sinelnikov, I., Krishnamurthy, R., Eisner, R., Gautam, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016957 · Cited by 1,703 · cited 1×
“Another study evaluating the human serum metabolome found a CV of 76% for PGE2 among 70 healthy subjects [53].”
BackgroundOPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification
Bylesjö, M., Rantalainen, M., Cloarec, O., Nicholson, J. K., Holmes, E., & Trygg, J. (2006) · Journal of Chemometrics · doi:10.1002/cem.1006 · Cited by 1,475
Self-citationLee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243 · cited 1×
“0005), which is in agreement with previous studies and meta-analyses showing approximately 25–30% decreases in TG in healthy subjects in response to 3-4 g/d EPA + DHA [36,37].”
ResultRizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA · doi:10.1001/2012.jama.11374 · Cited by 960
CV‐ANOVA for significance testing of PLS and OPLS® models
Eriksson, L., Trygg, J., & Wold, S. (2008) · Journal of Chemometrics · doi:10.1002/cem.1187 · Cited by 734
Self-citationLipoprotein Particle Analysis by Nuclear Magnetic Resonance Spectroscopy
Jeyarajah, E. J., Cromwell, W. C., & Otvos, J. D. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.006 · Cited by 732 · cited 1×
“The lipoprotein particle concentrations were quantified from the amplitudes of the lipid methyl group NMR signals according to previously published and validated methods [31].”
MethodPLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690 · cited 1×
“This result has come as a surprise after several decades of reports of beneficial effects, starting with the early studies in the 1970s that found low rates of heart disease in Inuit populations with high ω3 diets [2].”
ResultPLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 603
QUARTAN MALARIAL NEPHROTIC SYNDROME
Hendrickse, R. G., Adeniyi, A., Edington, G. M., Glasgow, E. F., White, R. H. R., & Houba, V. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91373-6 · Cited by 447
Lack of benefit of dietary advice to men with angina: results of a controlled trial
Burr, M. L., Ashfield-Watt, P. A. L., Dunstan, F. D. J., Fehily, A. M., Breay, P., Ashton, T., Zotos, P. C., Haboubi, N. A. A., & Elwood, P. C. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601539 · Cited by 409 · cited 1×
“Conflicting reports arose as early as 9 years ago, when the DART-2 trial, discovered an apparent harmful effect of ω3 taken as fish oil supplements [3].”
Background(n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
Mozaffarian, D., & Wu, J. H. Y. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.149633 · Cited by 368 · cited 1×
“The effects on lipoprotein particle distribution, including a decrease in VLDL size, increases in LDL and HDL size, and increases or decreases in LDL and HDL cholesterol are inconsistent and may be due to differences in the specific effects of the individual long chain ω3 EPA and DHA [10-12] as well as genetic factors…”
BackgroundTowards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids
Harris, W. S., Mozaffarian, D., Lefevre, M., Toner, C. D., Colombo, J., Cunnane, S. C., Holden, J. M., Klurfeld, D. M., Morris, M. C., & Whelan, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.101329 · Cited by 356 · cited 9×
“Intakes of the long-chain EPA and DHA are only about 130 mg/d [6].”
BackgroundInfluentialXie, L., & Innis, S. M. (2008) · The Journal of Nutrition · doi:10.3945/jn.108.096156 · Cited by 330 · cited 1×
“Delta-5 desaturase (FADS1) and delta-6 desaturase (FADS2) polymorphisms have been shown to be highly influential in plasma, red blood cell, and milk EPA and DHA composition [43-47], and may have played a role in the divergent EPA and DHA levels among subjects in this study.”
BackgroundYang, J., Schmelzer, K., Georgi, K., & Hammock, B. D. (2009) · Analytical Chemistry · doi:10.1021/ac901282n · Cited by 310 · cited 2×
“The optimized chromatographic conditions and the MRM transitions, as well as extraction efficiencies and validation (including coefficients of variation) were reported previously [30].”
MethodSelf-citationLee, T. H., Menica-Huerta, J. M., Shih, C., Corey, E. J., Lewis, R. A., & Austen, K. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43363-1 · Cited by 304
Fatty acids in cardiovascular health and disease: A comprehensive update
Baum, S. J., Kris-Etherton, P. M., Willett, W. C., Lichtenstein, A. H., Rudel, L. L., Maki, K. C., Whelan, J., Ramsden, C. E., & Block, R. C. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.04.077 · Cited by 277 · cited 1×
“A recent comprehensive update from an expert panel concluded that a key knowledge gap in understanding the effects of ω3 FA in modifying disease risk is the ability to identify those groups of individuals for whom they are beneficial and those for whom they are not beneficial, as well as the effective dosages and form…”
BackgroundLipid metabolome-wide effects of the PPARγ agonist rosiglitazone
Watkins, S. M., Reifsnyder, P. R., Pan, H.-J., German, J. B., & Leiter, E. H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200169-jlr200 · Cited by 274 · cited 1×
“method described by Watkins et al [27].”
Self-citationLee, T. H., Mencia-Huerta, J. M., Shih, C., Corey, E. J., Lewis, R. A., & Austen, K. F. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111612 · Cited by 270 · cited 2×
“Previous studies (in vitro, animal, and human) have found fish oil and ω3 FA reduce ARA-derived eicosanoids [14-18,48-51].”
BackgroundJacobson, T. A., Glickstein, S. B., Rowe, J. D., & Soni, P. N. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.10.018 · Cited by 263
Kelley, D. S., Taylor, P. C., Nelson, G. J., Schmidt, P. C., Ferretti, A., Erickson, K. L., Yu, R., Chandra, R. K., & Mackey, B. E. (1999) · Lipids · doi:10.1007/s11745-999-0369-5 · Cited by 252
The differential effects of EPA and DHA on cardiovascular risk factors
Cottin, S. C., Sanders, T. A., & Hall, W. L. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000061 · Cited by 247 · cited 1×
“Other potential mechanisms by which ω3 FA may be reducing heart disease risk include lowering plasma triglycerides [7], modifying lipoprotein particle size, decreasing blood pressure, as well as inhibiting platelet aggregation [8].”
BackgroundO2‐PLS for qualitative and quantitative analysis in multivariate calibration
Trygg, J. (2002) · Journal of Chemometrics · doi:10.1002/cem.724 · Cited by 238 · cited 1×
“Orthogonal 2 projections to latent structures (O2PLS) was used to investigate co-dependencies in the data [34].”
MethodSelf-citationApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1990 · Cited by 215 · cited 1×
“Previous studies have shown that ω3 shift VLDL toward smaller particles in men [39].”
ResultKoletzko, B., Lattka, E., Zeilinger, S., Illig, T., & Steer, C. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.006189 · Cited by 178 · cited 1×
“Delta-5 desaturase (FADS1) and delta-6 desaturase (FADS2) polymorphisms have been shown to be highly influential in plasma, red blood cell, and milk EPA and DHA composition [43-47], and may have played a role in the divergent EPA and DHA levels among subjects in this study.”
BackgroundMoltó-Puigmartí, C., Plat, J., Mensink, R. P., Müller, A., Jansen, E., Zeegers, M. P., & Thijs, C. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28789 · Cited by 171 · cited 1×
“Delta-5 desaturase (FADS1) and delta-6 desaturase (FADS2) polymorphisms have been shown to be highly influential in plasma, red blood cell, and milk EPA and DHA composition [43-47], and may have played a role in the divergent EPA and DHA levels among subjects in this study.”
BackgroundDose-response effects of fish-oil supplementation in healthy volunteers
Blonk, M., Bilo, H., Nauta, J., Popp-Snijders, C., Mulder, C., & Donker, A. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.1.120 · Cited by 162 · cited 1×
“Previous studies investigating EPA and DHA incorporation into serum or plasma lipid pools have shown increases in the range of 4-fold to 8-fold at similar supplementation doses as in the present study [54,55].”
ResultEffects of sample handling and storage on quantitative lipid analysis in human serum
Zivkovic, A. M., Wiest, M. M., Nguyen, U. T., Davis, R., Watkins, S. M., & German, J. B. (2009) · Metabolomics · doi:10.1007/s11306-009-0174-2 · Cited by 154 · cited 1×
“variation for this analysis were reported previously [28].”
Self-citationShearer, G. C., Harris, W. S., Pedersen, T. L., & Newman, J. W. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m900193-jlr200 · Cited by 152
de Roos, B., Mavrommatis, Y., & Brouwer, I. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00189.x · Cited by 151
Gillingham, L. G., Harding, S., Rideout, T. C., Yurkova, N., Cunnane, S. C., Eck, P., & Jones, P. J. H. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.043117 · Cited by 148
Bernstein, A. M., Ding, E. L., Willett, W. C., & Rimm, E. B. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.148973 · Cited by 148 · cited 1×
“The effects on lipoprotein particle distribution, including a decrease in VLDL size, increases in LDL and HDL size, and increases or decreases in LDL and HDL cholesterol are inconsistent and may be due to differences in the specific effects of the individual long chain ω3 EPA and DHA [10-12] as well as genetic factors…”
BackgroundGender and racial differences in lipoprotein subclass distributions: the STRRIDE study
Johnson, J. L., Slentz, C. A., Duscha, B. D., Samsa, G. P., McCartney, J. S., Houmard, J. A., & Kraus, W. E. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.018 · Cited by 131
Hartweg, J., Farmer, A. A., Perera, R., Holman, R. R., & Neil, H. A. W. (2007) · Diabetologia · doi:10.1007/s00125-007-0695-z · Cited by 125
Do FADS genotypes enhance our knowledge about fatty acid related phenotypes?
Lattka, E., Illig, T., Heinrich, J., & Koletzko, B. V. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.11.005 · Cited by 121 · cited 1×
“Delta-5 desaturase (FADS1) and delta-6 desaturase (FADS2) polymorphisms have been shown to be highly influential in plasma, red blood cell, and milk EPA and DHA composition [43-47], and may have played a role in the divergent EPA and DHA levels among subjects in this study.”
BackgroundKrokan, H. E., Bjerve, K. S., & Mørk, E. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90266-c · Cited by 109 · cited 1×
“Previous studies investigating EPA and DHA incorporation into serum or plasma lipid pools have shown increases in the range of 4-fold to 8-fold at similar supplementation doses as in the present study [54,55].”
ResultKeenan, A. H., Pedersen, T. L., Fillaus, K., Larson, M. K., Shearer, G. C., & Newman, J. W. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p025577 · Cited by 106 · cited 2×
“This is in agreement with previous studies, which showed similar increases in phospholipid EPA and DHA [20,22,42].”
BackgroundResultHarsløf, L. B. S., Larsen, L. H., Ritz, C., Hellgren, L. I., Michaelsen, K. F., Vogel, U. B., & Lauritzen, L. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.058685 · Cited by 96
Lopez-Huertas, E. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001572 · Cited by 93 · cited 1×
“Other potential mechanisms by which ω3 FA may be reducing heart disease risk include lowering plasma triglycerides [7], modifying lipoprotein particle size, decreasing blood pressure, as well as inhibiting platelet aggregation [8].”
BackgroundLeBlanc, C. J., Horohov, D. W., Bauer, J. E., Hosgood, G. L., & Mauldin, G. E. (2008) · American Journal of Veterinary Research · doi:10.2460/ajvr.69.4.486 · Cited by 85 · cited 1×
“Previous studies (in vitro, animal, and human) have found fish oil and ω3 FA reduce ARA-derived eicosanoids [14-18,48-51].”
BackgroundSerum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations
Zivkovic, A. M., Yang, J., Georgi, K., Hegedus, C., Nording, M. L., O’Sullivan, A., German, J. B., Hogg, R. J., Weiss, R. H., Bay, C., et al. (2012) · Metabolomics · doi:10.1007/s11306-012-0417-5 · Cited by 84
Self-citationOttestad, I., Hassani, S., Borge, G. I., Kohler, A., Vogt, G., Hyötyläinen, T., Orešič, M., Brønner, K. W., Holven, K. B., Ulven, S. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042550 · Cited by 83
Kelley, D. S., & Adkins, Y. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665112000080 · Cited by 62
Thifault, É., Cormier, H., Bouchard‐Mercier, A., Rudkowska, I., Paradis, A.-M., Garneau, V., Ouellette, C., Lemieux, S., Couture, P., & Vohl, M. (2013) · Lifestyle Genomics · doi:10.1159/000350744 · Cited by 54 · cited 2×
“0005), which is in agreement with previous studies and meta-analyses showing approximately 25–30% decreases in TG in healthy subjects in response to 3-4 g/d EPA + DHA [36,37].”
BackgroundResultLundström, S. L., Yang, J., Brannan, J. D., Haeggström, J. Z., Hammock, B. D., Nair, P. K., O’Byrne, P. M., Dahlén, S., & Wheelock, C. E. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200827 · Cited by 53 · cited 4×
“This is in agreement with previous studies, which showed similar increases in phospholipid EPA and DHA [20,22,42].”
BackgroundResultSelf-citationSecondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel
Burr, M. L. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005241 · Cited by 53 · cited 1×
“Subsequently, several insightful reviews and commentaries have highlighted the need to personalize dietary interventions such as ω3 fatty acid intake to individual needs and to consider the broader context of the overall diet and environment [4,5].”
BackgroundFish oil supplementation alters circulating eicosanoid concentrations in young healthy men
Zulyniak, M. A., Perreault, M., Gerling, C., Spriet, L. L., & Mutch, D. M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.004 · Cited by 51
Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease?
Burillo, E., Martin-Fuentes, P., Mateo-Gallego, R., Baila-Rueda, L., Cenarro, A., Ros, E., & Civeira, F. (2012) · Current Vascular Pharmacology · doi:10.2174/157016112800812845 · Cited by 43
Dietary n − 3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes
von Schacky, C., Kiefl, R., Marcus, A. J., Broekman, M. J., & Kaminski, W. E. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90278-h · Cited by 39 · cited 2×
“Previous studies (in vitro, animal, and human) have found fish oil and ω3 FA reduce ARA-derived eicosanoids [14-18,48-51].”
BackgroundKelley, D. S., Adkins, Y., Woodhouse, L. R., Swislocki, A., Mackey, B. E., & Siegel, D. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0081 · Cited by 33 · cited 1×
“The effects on lipoprotein particle distribution, including a decrease in VLDL size, increases in LDL and HDL size, and increases or decreases in LDL and HDL cholesterol are inconsistent and may be due to differences in the specific effects of the individual long chain ω3 EPA and DHA [10-12] as well as genetic factors…”
BackgroundPei, J., Zhao, Y., Huang, L., Zhang, X., & Wu, Y. (2012) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2012.04.005 · Cited by 30
Armstrong, P., Kelley, D. S., Newman, J. W. I., Staggers, F. E., Hartiala, J., Allayee, H., & Stephensen, C. B. (2012) · Journal of Nutrition · doi:10.3945/jn.112.159814 · Cited by 23 · cited 1×
“The effects on lipoprotein particle distribution, including a decrease in VLDL size, increases in LDL and HDL size, and increases or decreases in LDL and HDL cholesterol are inconsistent and may be due to differences in the specific effects of the individual long chain ω3 EPA and DHA [10-12] as well as genetic factors…”
BackgroundBryan, D., Forsyth, K. D., Hart, P. H., & Gibson, R. A. (2006) · Lipids · doi:10.1007/s11745-006-5059-9 · Cited by 16 · cited 1×
“Previous studies (in vitro, animal, and human) have found fish oil and ω3 FA reduce ARA-derived eicosanoids [14-18,48-51].”
BackgroundCansell, M., Moussaoui, N., & MANCINI, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.014 · Cited by 15 · cited 1×
“Previous studies (in vitro, animal, and human) have found fish oil and ω3 FA reduce ARA-derived eicosanoids [14-18,48-51].”
BackgroundLangerhuus, S. N., Tønnesen, E. K., Jensen, K. H., Damgaard, B. M., Halekoh, U., & Lauridsen, C. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003503 · Cited by 9 · cited 1×
“Previous studies (in vitro, animal, and human) have found fish oil and ω3 FA reduce ARA-derived eicosanoids [14-18,48-51].”
BackgroundComparative effects of omega-3 fatty acids in men and women.
Mueller, B. A., Talbert, R. L., & Tegeler, C. H. (1989) · PubMed · Cited by 3
Freese, R., Basu, S., & Mutanen, M. L. (1999) · Lipids · doi:10.1007/bf02562331 · Cited by 2
Cited by
Dyall, S. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00052 · Cited by 943
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 798
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
D’Angelo, S., Motti, M. L., & Meccariello, R. (2020) · Nutrients · doi:10.3390/nu12092751 · Cited by 250
“There is also a degree of individual change in the lipidome following ω-3 integration in humans, which may be a factor in the equivocal metabolic conversion measured in many human integration trials [30,33].”
BackgroundMcGlory, C., Calder, P. C., & Nunes, E. A. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00144 · Cited by 218
“Therefore, dietary or supplemental intake of preformed EPA and DHA intake is necessary to significantly enhance the EPA and DHA content of biological tissues in humans with known significant inter-individual variability (10).”
Background
Metadata
- Authors
- Nording, M. L., Yang, J., Georgi, K., Hegedus Karbowski, C., German, J. B., Weiss, R. H., Hogg, R. J., Trygg, J., Hammock, B. D., & Zivkovic, A. M.
- Affiliations
- University of California, Davis (US)
- UC Davis Comprehensive Cancer Center (US)
- Sacramento VA Medical Center (US)
- Umeå University (SE)
- Corresponding author
- Zivkovic, Angela M.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-24
- Volume
- 8
- Issue
- 10
- Pages
- e76575
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3811983
- OpenAlex
- W2162751353
- Cited by
- 100
- References
- 59
- Citations by year
- 2025: 6 · 2024: 6 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 13 · 2019: 8 · 2018: 15 · 2017: 12 · 2016: 5 · 2015: 13 · 2014: 10 · 2013: 1
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- California Dairy Research Foundation
- American Asthma Foundation (R01 ES002710, 09-0269)
- VINNOVA (2010-02070)
- Svenska Forskningsrådet Formas (2010-303)
- National Institutes of Health (DK097154, ES002710, ES011269)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK049368, U24DK097154, DK 097154, DK49368, R01 DK49368)
- National Institute of Environmental Health Sciences (P42ES004699, P42 ES011269, ES002710, ES011269, P01ES011269, R01ES002710, NIEHS R01 ES002710)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, lipidomics, oxylipins, interindividual variability, prostaglandin E2, thromboxane B2, 12-hydroxyeicosatetraenoic acid, arachidonic acid metabolites, lipoxygenase metabolites, cyclooxygenase metabolites, healthy volunteers
- MeSH terms
- Adult, Female, Humans, Lipids, Lipoproteins, Male, Middle Aged, Pilot Projects, Risk Factors, Fatty Acids, Omega-3, Dietary Supplements, Lipid Metabolism, Oxylipins, Metabolomics, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.